JPM vs KEY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
KeyCorp presents a stark contrast between attractive valuation and poor fundamental health. While the stock trades below its Graham Number ($24.29) and Intrinsic Value ($48.08), the Piotroski F-Score of 2/9 indicates significant weakness in financial health and operational efficiency. Strong recent earnings growth and a sustainable dividend are offset by bearish insider sentiment and a severely negative technical trend (10/100). The disconnect between analyst 'buy' ratings and the deterministic health scores suggests a value trap risk.
Compare Another Pair
Related Comparisons
JPM vs KEY: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and KeyCorp (KEY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.